AMETEK Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de AMETEK de 8.2% y 7.7% por año respectivamente. Se prevé que el BPA crezca en un 8.3% al año. Se espera que la rentabilidad financiera sea de 14.6% en 3 años.
Información clave
8.2%
Tasa de crecimiento de los beneficios
8.3%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Electrical | 18.1% |
Tasa de crecimiento de los ingresos | 7.7% |
Rentabilidad financiera futura | 14.6% |
Cobertura de analistas | Good |
Última actualización | 21 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
AMETEK, Inc.'s (NYSE:AME) Shareholders Might Be Looking For Exit
Apr 26AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly
Apr 14Here's Why We Think AMETEK (NYSE:AME) Might Deserve Your Attention Today
Mar 21Slowing Rates Of Return At AMETEK (NYSE:AME) Leave Little Room For Excitement
Mar 08A Look At The Intrinsic Value Of AMETEK, Inc. (NYSE:AME)
Feb 20AMETEK Q4: Overall Industrial Market Slowdown (Rating Downgrade)
Feb 09AMETEK, Inc.'s (NYSE:AME) Price Is Out Of Tune With Earnings
Jan 20AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly
Jan 08Meet AMETEK, One Of The Best Industrial Compounders On The Market
Dec 26Why AMETEK, Inc. (NYSE:AME) Could Be Worth Watching
Dec 15AMETEK (NYSE:AME) Hasn't Managed To Accelerate Its Returns
Dec 03Are Investors Undervaluing AMETEK, Inc. (NYSE:AME) By 36%?
Nov 20Ametek Q3 Results And New Deals: Impressive, Simply Impressive
Oct 31Does AMETEK (NYSE:AME) Deserve A Spot On Your Watchlist?
Oct 26These 4 Measures Indicate That AMETEK (NYSE:AME) Is Using Debt Safely
Oct 02Is There Now An Opportunity In AMETEK, Inc. (NYSE:AME)?
Sep 05Ametek: A Collection Of Niche Industrial Businesses
Aug 26Return Trends At AMETEK (NYSE:AME) Aren't Appealing
Aug 21Is AMETEK, Inc. (NYSE:AME) Trading At A 27% Discount?
Aug 07With EPS Growth And More, AMETEK (NYSE:AME) Makes An Interesting Case
Jul 11Is AMETEK (NYSE:AME) A Risky Investment?
Jun 27Ametek: Earnings Growth And Automation Trends Make It A Buy
Jun 22Is Now An Opportune Moment To Examine AMETEK, Inc. (NYSE:AME)?
May 31AMETEK, Inc. (NYSE:AME) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 08Investors Met With Slowing Returns on Capital At AMETEK (NYSE:AME)
Apr 26Do AMETEK's (NYSE:AME) Earnings Warrant Your Attention?
Apr 01AMETEK (NYSE:AME) Could Easily Take On More Debt
Mar 17When Should You Buy AMETEK, Inc. (NYSE:AME)?
Feb 14Ametek raises dividend by ~14% to $0.25/share
Feb 09Are Investors Undervaluing AMETEK, Inc. (NYSE:AME) By 21%?
Feb 03Ametek Q4 2022 Earnings Preview
Feb 01Ametek: Shares Are Getting Rather Pricey
Jan 24Returns On Capital At AMETEK (NYSE:AME) Have Stalled
Jan 23With EPS Growth And More, AMETEK (NYSE:AME) Makes An Interesting Case
Jan 01AMETEK (NYSE:AME) Could Easily Take On More Debt
Dec 10Calculating The Fair Value Of AMETEK, Inc. (NYSE:AME)
Nov 01Ametek Q3 2022 Earnings Preview
Oct 31When Should You Buy AMETEK, Inc. (NYSE:AME)?
Oct 21Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 8,363 | 1,683 | 1,965 | 2,370 | 6 |
12/31/2025 | 7,810 | 1,541 | 1,816 | 2,040 | 15 |
12/31/2024 | 7,404 | 1,392 | 1,598 | 1,873 | 16 |
12/31/2023 | 6,597 | 1,313 | 1,599 | 1,735 | N/A |
9/30/2023 | 6,492 | 1,277 | 1,445 | 1,580 | N/A |
6/30/2023 | 6,421 | 1,235 | 1,300 | 1,434 | N/A |
3/31/2023 | 6,289 | 1,193 | 1,202 | 1,335 | N/A |
12/31/2022 | 6,151 | 1,160 | 1,010 | 1,149 | N/A |
9/30/2022 | 6,029 | 1,134 | 922 | 1,046 | N/A |
6/30/2022 | 5,918 | 1,094 | 904 | 1,026 | N/A |
3/31/2022 | 5,789 | 1,043 | 958 | 1,077 | N/A |
12/31/2021 | 5,547 | 990 | 1,050 | 1,160 | N/A |
9/30/2021 | 5,242 | 929 | 1,160 | 1,264 | N/A |
6/30/2021 | 4,928 | 877 | 1,179 | 1,267 | N/A |
3/31/2021 | 4,554 | 811 | 1,220 | 1,295 | N/A |
12/31/2020 | 4,540 | 872 | 1,207 | 1,281 | N/A |
9/30/2020 | 4,646 | 872 | 1,159 | 1,237 | N/A |
6/30/2020 | 4,796 | 888 | 1,171 | 1,257 | N/A |
3/31/2020 | 5,073 | 938 | 1,091 | 1,189 | N/A |
12/31/2019 | 5,159 | 861 | 1,012 | 1,114 | N/A |
9/30/2019 | 5,125 | 852 | 972 | 1,068 | N/A |
6/30/2019 | 5,041 | 823 | 891 | 988 | N/A |
3/31/2019 | 4,961 | 801 | 853 | 944 | N/A |
12/31/2018 | 4,846 | 778 | 843 | 926 | N/A |
9/30/2018 | 4,718 | 805 | 805 | 882 | N/A |
6/30/2018 | 4,609 | 767 | 796 | 872 | N/A |
3/31/2018 | 4,465 | 724 | 794 | 868 | N/A |
12/31/2017 | 4,300 | 681 | 758 | 833 | N/A |
9/30/2017 | 4,130 | 552 | N/A | 828 | N/A |
6/30/2017 | 3,990 | 529 | N/A | 758 | N/A |
3/31/2017 | 3,903 | 517 | N/A | 748 | N/A |
12/31/2016 | 3,840 | 512 | N/A | 757 | N/A |
9/30/2016 | 3,855 | 540 | N/A | 709 | N/A |
6/30/2016 | 3,909 | 566 | N/A | 728 | N/A |
3/31/2016 | 3,935 | 583 | N/A | 702 | N/A |
12/31/2015 | 3,974 | 591 | N/A | 673 | N/A |
9/30/2015 | 4,010 | 606 | N/A | 686 | N/A |
6/30/2015 | 4,044 | 591 | N/A | 695 | N/A |
3/31/2015 | 4,031 | 586 | N/A | 687 | N/A |
12/31/2014 | 4,022 | 584 | N/A | 726 | N/A |
9/30/2014 | 3,940 | 568 | N/A | 722 | N/A |
6/30/2014 | 3,798 | 554 | N/A | 692 | N/A |
3/31/2014 | 3,687 | 532 | N/A | 665 | N/A |
12/31/2013 | 3,594 | 517 | N/A | 661 | N/A |
9/30/2013 | 3,493 | 501 | N/A | 644 | N/A |
6/30/2013 | 3,443 | 489 | N/A | 641 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (8.2% al año) de AME es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (8.2% al año) de AME crezcan menos que el mercado US (14.4% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de AME crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (7.7% al año) de AME crezcan más despacio que el mercado de US (7.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7.7% al año) de AME crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de AME sea baja dentro de 3 años (14.6%).